Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Mouton

Showing results (51-60 of 392) with videos related to

Pageof 40
Sort By:
Antimicrobial Agents and Chemotherapy|March 30, 2004
Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazoleJavier Afeltra, Roxana G Vitale, Johan W Mouton, et al.
Therapeutic Drug Monitoring|March 27, 2003
Thoughts on "Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates"Matthijs de Hoog, Johan W Mouton, John N van den Anker
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificansJ Meletiadis, J W Mouton, J F Meis, et al.
International Journal of Antimicrobial Agents|January 28, 2021
In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infectionsMaria-Ioanna Beredaki, Maiken Cavling Arendrup, Johan W Mouton, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 5, 2019
Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?Rixt A Wijma, Fiona Fransen, Anouk E Muller, et al.
AIDS (London, England)|June 16, 2001
Prevention of invasive aspergillosis in AIDS by sulfamethoxazoleJ Afeltra, J F Meis, J W Mouton, et al.
Journal of Clinical Microbiology|February 7, 2001
Analysis of growth characteristics of filamentous fungi in different nutrient mediaJ Meletiadis, J F Meis, J W Mouton, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 1, 1995
[Congenital cystic duplication of the stomach--a rare surgical disease]A Glättli, W Mouton, M Kaufmann, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2017
<i>In Vitro</i> Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF DeterminationJ Meletiadis, I Curfs-Breuker, J F Meis, et al.
Lancet (London, England)|March 11, 1995
Why monitor peak vancomycin concentrations?M de Hoog, J W Mouton, J N van den Anker
Pageof 40

Showing results (51-60 of 392) with videos related to

Sort By:
Pageof 40
Antimicrobial Agents and Chemotherapy|March 30, 2004
Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazoleJavier Afeltra, Roxana G Vitale, Johan W Mouton, et al.
Therapeutic Drug Monitoring|March 27, 2003
Thoughts on "Population pharmacokinetics and relationship between demographic and clinical variables and pharmacokinetics of gentamicin in neonates"Matthijs de Hoog, Johan W Mouton, John N van den Anker
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 13, 2001
Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificansJ Meletiadis, J W Mouton, J F Meis, et al.
International Journal of Antimicrobial Agents|January 28, 2021
In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infectionsMaria-Ioanna Beredaki, Maiken Cavling Arendrup, Johan W Mouton, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|April 5, 2019
Optimizing dosing of nitrofurantoin from a PK/PD point of view: What do we need to know?Rixt A Wijma, Fiona Fransen, Anouk E Muller, et al.
AIDS (London, England)|June 16, 2001
Prevention of invasive aspergillosis in AIDS by sulfamethoxazoleJ Afeltra, J F Meis, J W Mouton, et al.
Journal of Clinical Microbiology|February 7, 2001
Analysis of growth characteristics of filamentous fungi in different nutrient mediaJ Meletiadis, J F Meis, J W Mouton, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 1, 1995
[Congenital cystic duplication of the stomach--a rare surgical disease]A Glättli, W Mouton, M Kaufmann, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2017
<i>In Vitro</i> Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF DeterminationJ Meletiadis, I Curfs-Breuker, J F Meis, et al.
Lancet (London, England)|March 11, 1995
Why monitor peak vancomycin concentrations?M de Hoog, J W Mouton, J N van den Anker
Pageof 40